List of offered Markers         

Markers

Pathologies

CEA

Colorectal, pancreas, lung, breast, stomach, thyroid, female genital cancers.

 

AFP

Liver, ovary, testicle.

 

PSA FreePSA

Prostate.

 

CA 15-3

Breast.

 

CA 19-9

Colorectal cancer, pancreas, stomach, bile duct.

 

CA 125

Ovary.

CA 72-4

Stomach.

BHCG

Testicle, ovary, liver, stomach, pancreas.

B2M

Haematopoietic system.

NSE

Lung: small cells cancers ("SCLC"); neuroblastomas, pancreas.

CYFRA 21-1

Lung: non-small cells cancers ("NSCLC"); uterus,breast.

PATHOLOGIES and TUMOR MARKERS

BREAST

Epithelial tumors

CA15-3, CEA, CYFRA 21-1

OVARY

Adenocarcinoma

CA125

Mucinous adenocarcinoma

CA19-9, CEA

Germinative tumors

AFP, HCG

UTERUS

Cervix (epiderm. tumors) (95%)

SCC, Cyfra21-1

Adenocarcinoma (5%)

CA125

Corpus adenocarcinoma (95%)

CA125

Mucinous tumors

CA19-9, CEA

PROSTATE

Adenocarcinoma

PSA, FPSA

TESTICLE

Seminoma

HCG

Non seminomous tumors

HCG, AFP

COLORECTAL

Adenocarcinoma

CEA, CA 19-9, CA 125

PANCREAS

Adenocarcinoma

CA 19-9, CEA

Endocrine

CA 19-9, CEA, NSE

LIVER

Hepatocarcinoma

AFP, CEA

STOMACH

Adenocarcinoma

CA 72-4, CA 19-9, CEA

ESOPHAGUS

Adenocarcinoma

CEA

Epidermoidis

SCC, CYFRA 21-1

THYROID

Medullar

CEA, NSE

Differential

Thyroglobuline

LUNG

Adenocarcinoma

CEA, CA19-9, CA125

Epidermoidis

CYFRA21-1

Small cells

NSE, CA125